Indegene Limited (BOM:544172)
657.60
+12.40 (1.92%)
At close: Nov 20, 2026
Indegene Market Cap
Indegene has a market cap or net worth of 158.43 billion as of November 20, 2026. Its market cap has increased by 28.25% in one year.
Market Cap
158.43B
Enterprise Value
147.44B
Revenue
41.31B
Global Rank
n/a
Country Rank
n/a
PE Ratio
38.65
ChartMarket Cap Chart
Since May 9, 2024, Indegene's market cap has increased from 108.15B to 158.43B, an increase of 46.49%. That is a compound annual growth rate of 16.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 158.43B | 26.83% |
| Dec 31, 2025 | 124.91B | -13.52% |
| Dec 31, 2024 | 144.45B | 33.56% |
| May 9, 2024 | 108.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.52T |
| Divi's Laboratories | 2.97T |
| Apollo Hospitals Enterprise | 1.32T |
| Lenskart Solutions | 1.28T |
| Alivus Life Sciences | 176.79B |
| Pfizer | 175.49B |
| Dr. Agarwal's Health Care | 175.47B |
| Molbio Diagnostics | 172.28B |